Last $14.02 USD
Change Today +0.01 / 0.07%
Volume 398.2K
HTGC On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

hercules technology growth (HTGC) Snapshot

Open
$13.96
Previous Close
$14.01
Day High
$14.17
Day Low
$13.87
52 Week High
12/2/13 - $17.25
52 Week Low
04/22/13 - $12.28
Market Cap
866.8M
Average Volume 10 Days
647.0K
EPS TTM
$1.42
Shares Outstanding
61.8M
EX-Date
03/6/14
P/E TM
9.9x
Dividend
$1.24
Dividend Yield
8.35%
Current Stock Chart for HERCULES TECHNOLOGY GROWTH (HTGC)

hercules technology growth (HTGC) Related Bloomberg News

View More Bloomberg News

hercules technology growth (HTGC) Related Businessweek News

View More BusinessWeek News

hercules technology growth (HTGC) Details

Hercules Technology Growth Capital, Inc. is a private equity, venture capital, and venture debt firm specializing in providing debt and equity to privately held venture capital and private equity backed companies and select publicly-traded companies. It offers growth and emerging growth capital and structured debt financing to companies at all stages of development and specializes in venture debt in the forms of senior secured and subordinated working capital loans, senior revolving loans and bridge loans, venture leasing, and select direct equity capital. The firm also provides private equity financing for recapitalizations, leveraged buyouts, spin-off transactions, mergers and acquisitions, public to private financings, and PIPEs. It invests in debt and equity investments in later stage, venture, and lower middle market companies. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. It primarily provides senior secured revolvers and term loans; Unitranche and "one-stop" financings; and mezzanine debt, including "last-out" and second lien financings. The firm typically provides non-control financing solutions used for refinancing of existing indebtedness; acquisition financing – control buyouts and minority recaps; dividend recaps; and growth capital. It prefers to invest in technology, energy technology, health care, life sciences, business services, and manufacturing sectors. Within technology, the firm seeks companies characterized by products or services that require advanced technologies, including communications and telecommunications infrastructure, computing and storage infrastructure, digital media and consumer Internet, e-commerce, enterprise software and services, mobility, networking systems, security, semiconductors components, clean technology, and technology enabled services. Within energy technology, it invests in advanced materials (bio-chemicals, solar materials), carbon (capture, conversion, and abatement), energy efficiency technologies (smart grid, demand response, and lighting), generation (solar, biofuels, and wind), recycling (conversion, diversion, and programs), storage (batteries, fuel cells), technology (management, measurement, controls), transportation (engine design, infrastructure), waste, agriculture, and water (treatment, waste water, and desalination). Within life sciences, the firm invests in biotechnology (including diagnostics), drug discovery and drug delivery, healthcare services, life sciences instrumentation, medical devices, health care services, and specialty pharmaceuticals. It provides growth capital financing solutions with a focus on buy-out or spin-out financing solutions; cash flow based customized financing solutions; company, asset specific, or intellectual property acquisition; convertible, subordinated and/or mezzanine loans; domestic or international expansion; growth capital term loans; vendor financing; established stages of development; and venture debt, asset-based financings with a focus on cash flow-based customized financing solutions; domestic and international account receivable credit lines or revolvers; equipment and infrastructure financing; equipment leases; and facilities build-out and/or expansion. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition with a focus on dividend recapitalizations and other sources of investor liquidity; IPO financing; and merger and acquisition financing. It also provides seed and early-stage financing. It provides specialized energy technology industry financings with a focus on international special purpose entity (SPE) financing; pilot and production facility financing; pre-commercialization facility financing; situation-specific financing (satisfying customer contract requirements, pre-funding strategic relationship, etc.); and supplemental joint venture financing. The firm provides short-term bridge financing. It also provides asset-based financing with a focus on cleantech lab/testing facilities initial build-out and/or expansion; domestic and international working capital revolving lines of credit; equipment loans/leases; inventory build-out; manufacturing capacity expansion. Within life sciences, it provided growth capital financing solutions with a focus on royalty-based financing of existing or future new drugs or medical devices. The firm also provides asset-based financing with a focus on equipment leases and loans; facilities build-out and/or expansion (lab, manufacturing capacity, inventory, etc.). The firm also considers investment in the Mid-Atlantic regions particularly in the areas of software, biotech and information services. It seeks to invest in companies with capital needs from $5 million to $30 million and revenues of $10 million to $200 million, generating EBITDA of $2 million to $15 million, focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm provided loans in the range of $1 million and $30 million and can underwrite transactions up to $40 million. It seeks to provide emerging growth capital with focus on first institutional round (Series A/B). The firm also invests in expansion stage with focus on follow-on rounds of growth capital (Series B-F). It also co-invests with other private equity firms. Hercules Technology Growth Capital, Inc. was founded in December 2003 and is based in Palo Alto, California with additional offices across United States.

62 Employees
Last Reported Date: 02/27/14
Founded in 2003

hercules technology growth (HTGC) Top Compensated Officers

Co-Founder, Executive Chairman, Chief Executi...
Total Annual Compensation: $1.6M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $415.0K
Group Head of Life Sciences and Senior Managi...
Total Annual Compensation: $532.1K
Chief Credit Officer
Total Annual Compensation: $455.0K
Senior Managing Director and Group Head of En...
Total Annual Compensation: $450.0K
Compensation as of Fiscal Year 2012.

hercules technology growth (HTGC) Key Developments

Hercules Technology Growth Capital, Inc. Declares Fourth Quarter Cash Dividend Payable on March 17, 2014; Provides Dividend Guidance for 2014

Hercules Technology Growth Capital, Inc. announced that the Board of Directors has declared a fourth quarter cash dividend of $0.31 per share that will be payable on March 17, 2014 to shareholders of record as of March 10, 2014. The company intends to distribute approximately $3.8 million or approximately $0.06 per share, of spillover earnings from 2013 to its shareholders in 2014.

Hercules Technology Growth Capital Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2013

Hercules Technology Growth Capital Inc. reported consolidated earnings results for the fourth quarter and year ended December 31, 2013. For the quarter, the company reported total interest income of $28.265 million compared to $24.415 million for the same period of last year. Total investment income was $33.210 million compared to $27.395 million for the same period of last year. Net investment income was $18.864 million compared to $13.071 million for the same period of last year. Net increase in net assets resulting from operations was $24.897 million compared to $24.861 million for the same period of last year. Net investment income before investment gains and losses per basic share were $0.31 compared to $0.25 for the same period of last year. Total net realized gain on investments was $3.527 million against $1.119 million a year ago. Change in net assets per diluted share was $0.39 against $0.47 a year ago. Adjusted Change in net assets per common basic share was $0.41 compared to $0.47 a year ago. Adjusted net investment income before investment gains and losses per basic share was $0.31 compared to $0.25 a year ago. For the year, the company reported total interest income of $123.671 million compared to $87.603 million for the same period of last year. Total investment income was $139.713 million compared to $97.520 million for the same period of last year. Net investment income was $73.065 million compared to $48.107 million for the same period of last year. Net increase in net assets resulting from operations was $99.446 million compared to $46.759 million for the same period of last year. Net investment income before investment gains and losses per basic share were $1.22 compared to $0.96 for the same period of last year. Total net realized gain on investments was $14.836 million against $3.168 million a year ago. Adjusted Change in net assets per common basic share was $1.67 compared to $0.93 a year ago. Adjusted net investment income before investment gains and losses per basic share was $1.22 compared to $0.96 a year ago. As of December 31, 2013, net asset value per share was $10.51 on 61.8 million outstanding shares representing an increase of 7.8%, compared to $9.75 on 52.9 million outstanding shares and $10.42 on 61.8 million outstanding shares as of December 31, 2012 and September 30, 2013, respectively.

Hercules Technology Seeks Acquisitions

Hercules Technology Growth Capital, Inc. (NYSE:HTGC) is looking for acquisition opportunities. Manuel Henriquez, Chairman, Chief Executive Officer and Co-Founder said, “In 2014 we expect to make some major announcements on strategic initiatives that we're working on. We are working on expanding our product offering, our strategic partnerships, and including potential acquisitions of certain portfolios.”

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTGC:US $14.02 USD +0.01

HTGC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BlackRock Kelso Capital Corp $9.19 USD -0.01
Main Street Capital Corp $31.56 USD -0.08
New Mountain Finance Corp $14.37 USD +0.02
TICC Capital Corp $9.65 USD -0.04
Triangle Capital Corp $25.98 USD -0.01
View Industry Companies
 

Industry Analysis

HTGC

Industry Average

Valuation HTGC Industry Range
Price/Earnings 8.6x
Price/Sales 6.1x
Price/Book 1.3x
Price/Cash Flow 8.7x
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HERCULES TECHNOLOGY GROWTH, please visit www.htgc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.